Applications for BioPharma and Chemical sector awards open
BioPharmaChem Ireland Launches second Impact Awards
BioPharmaChem Ireland (BPCI), the Ibec group representing Ireland’s biopharmaceutical and chemical sectors, along with co-hosts Enterprise Ireland and IDA Ireland, has launched the second annual BioPharmaChem Impact Awards 2026.
The awards will honour outstanding achievements and potential within Ireland’s BioPharmaChem sector in Ireland, which generates €116 billion in exports annually and directly employs 65,000 people. The ceremony will be held as part of the BioPharmaChem Impact 2026 Conference on 6 May at the Intercontinental Hotel, Dublin.
Speaking about the awards programme, Sinead Keogh, Director of BioPharmaChem Ireland said:
“The BioPharmaChem Impact Awards are a primary showcase of the innovation, resilience, and collaboration that define Ireland’s global leadership in this sector. These awards provide a vital platform to recognise the people and partnerships driving meaningful progress across our entire community, highlighting the depth of R&D expertise and manufactuirng excellence that makes Ireland a global hub”
“As Ireland continues to strengthen its position as a global biopharma leader, this year’s conference will focus on the realities of achieving manufacturing excellence, building supply chain resilience, and delivering sustainable, future-ready operations. This arrives at a pivotal moment as Ireland prepares for its 2026 EU Presidency, and a major highlight of the event will be the official launch of the Indigenous BioPharmaChem Strategy, a landmark roadmap designed to accelerate the growth of home-grown innovators from proof-of-concept to full commercialisation. We are also delighted to introduce the ‘BioPharma Brew’ taking place the evening before the conference, a vibrant new event designed to showcase the next generation of innovators.”
The BioPharmaChem Impact Awards 2026 will recognise excellence across seven distinct categories: BioPharmaChem Company of the Year; Best Process Innovation / Digitalisation; Best Talent Strategy; BioPharmaChem Partner / Supplier of the Year; Collaboration in BioPharmaChem; Emerging BioPharmaChem Company of the Year; and Sustainable BioPharmaChem Company of the Year.
Cepta Duffy, Head of Life Sciences and Health Tech at Enterprise Ireland, commented:
“Ireland is regarded as a leading biopharma hub, bolstered by the dynamic of the strength and breath of the established multi-national cohort and the innovation emerging from the Irish indigenous and start-up life science base. The BioPharmaChem Impact Awards acknowledges the level of innovation and the beneficial impact of cross-collaboration within the ecosystem which in turn nurtures innovative thinking and brings positive change to the healthcare system.”
Rory Mullen, Head of BioPharma & Food at IDA Ireland, remarked: “IDA Ireland is delighted to partner with BPCI for the Impact awards. The Biopharma sector in Ireland,
is very important to IDA Ireland, and continues to have an enormous impact on the Irish economy and this event encourages the collaboration that enables its continued success.”
BPCI extends its sincere thanks to the 2026 Impact Awards sponsors, including Platinum sponsors Chemco Ireland, Frontier Scientific Solutions, and WuXi Biologics; Gold sponsors BioPharmaChem Skillnet, Brightbeam, Camida, DHL, EY, Indaver, PMTC, and SkyCell; and Silver sponsors Innopharma Education, LSC, Life Science Recruitment, Ibec Laboratory Apprenticeship, Micro Bio, and National Chemical Company.
More information on the awards and application process is available at bpcimpact.ie. The deadline for submissions is 27 March.
